Biotechnology companies have become...

Biotechnology companies have become the driving force behind novel drug research intended to treat orphan diseases in the United States, says a recent analysis by the Tufts Center for the research of Drug Development (Boston, MA). Between 1998 and 2001 biotech firms accounted for 65% of research into orphan unsalable articles and pharmaceutical firms accounted for 28%
Although biotech companies leadership nearly two-thirds of orphan unsalable article R&D, they market fewer than half of those strange drugs. Biotech firms receive 41%

Ibm Laptop Hard Drive , International Phone Card , Property In Bulgaria , Gifts For Women , Hoodia Gordonii Cactus